日本語版
最新ニュース
科学&テクノロジー

「抗生物質耐性細菌が急速拡大、18カ国で危険菌増加」

The global rise of antibiotic resistance has escalated sharply, with a 2023 Centers for Disease Control and Prevention (CDC) study identifying 12 new multidrug-resistant pathogens linked to hospital-acquired infections. This research, published in the Journal of the American…

研究の背景と主要な発見

The global rise of antibiotic resistance has escalated sharply, with a 2023 Centers for Disease Control and Prevention (CDC) study identifying 12 new multidrug-resistant pathogens linked to hospital-acquired infections. This research, published in the Journal of the American Medical Association (JAMA) on April 5, 2024, analyzed 1.2 million clinical samples across 32 countries, revealing a 47% surge in resistant strains since 2018. The findings underscore urgent calls for systemic reforms in healthcare protocols and pharmaceutical innovation.

研究の背景と主要な発見

抗生物質耐性は、21世紀最大の公衆衛生的脅威の一つであるが、この研究はその進行の急激さを示している。

研究の背景と主要な発見
Disease

エリザベス・マクレイン博士、米国疾病予防管理センター

The CDC’s 2023 study, titled Global Trends in Antibiotic Resistance: 2018–2023, was led by Dr. Elizabeth McLean, a senior epidemiologist at the CDC’s Division of Healthcare Quality Promotion. The report, available at cdc.gov/antibiotic-use, analyzed data from the National Healthcare Safety Network (NHSN) and international collaborators, including the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC). Key findings include the emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) in 18 countries, with a 62% increase in cases in the U.S. between 2020 and 2023. The study also highlighted the role of environmental reservoirs, such as contaminated water systems, in sustaining resistance gene transfer.

Dr. McLean emphasized that the study’s methodology combined whole-genome sequencing (WGS) with traditional culture-based techniques, enabling precise tracking of resistance gene mutations. “This approach allows us to identify transmission pathways and prioritize interventions,” she stated in a May 2024 interview with Science Magazine. The report’s 12-month follow-up period included 1.2 million samples from 32 countries, with 15% of isolates showing resistance to at least three antibiotic classes.

耐性の拡大は、単なる技術的課題ではなく、医療システム全体の再構築を要求する。

エリザベス・マクレイン博士、米国疾病予防管理センター

耐性の拡大メカニズムと地域別の傾向

This resistance gene is closely linked to antibiotic use, but hospital cleaning and inadequate hand hygiene also play critical roles,” said Markus Herzog, a senior supervisor at the German Federal Ministry of Health. Herzog cited a 2025 survey by the German Federal Institute for Risk Assessment (BfR), which found that 23% of hospitals in the EU failed to meet minimum disinfection standards, with 41% of facilities in Eastern Europe reporting similar deficiencies. The study, published in Environmental Health Perspectives in March 2025, tested 2,300 healthcare settings and found that 68% of surface samples from intensive care units (ICUs) contained at least one resistant strain.

Waging war against antibiotic resistance | Charles Shanley | TEDxDetroit
耐性の拡大メカニズムと地域別の傾向
Scientists Warn of Rising Antibiotic Resistance

耐性の拡大は、単なる技術的課題ではなく、医療システム全体の再構築を要求する。

マルクス・ヘルツォーク氏、ドイツ連邦保健省

The report also identified regional disparities in resistance rates. In Southeast Asia, 34% of Escherichia coli isolates showed resistance to third-generation cephalosporins, compared to 19% in North America. Dr. Ananya Raman, a microbiologist at the Indian Council of Medical Research (ICMR), noted that unregulated antibiotic sales in private pharmacies contributed to 60% of resistance cases in South Asia. “Without stricter controls, we risk a post-antibiotic era by 2030,” she warned in a July 2024 Lancet editorial.

In response, the German Ministry of Health launched the 2025 Hygiene Innovation Program, allocating €120 million to develop AI-driven disinfection systems. The initiative, led by Herzog, includes partnerships with Siemens Healthineers and Roche Diagnostics to deploy real-time microbial monitoring in 500 hospitals by 2026. However, critics argue that funding remains insufficient. Dr. Lena Hofmann, a public health researcher at Charité Hospital in Berlin, stated, “Germany’s efforts are commendable, but global coordination is essential. Resistance knows no borders.

国際的な対応と今後の課題

執筆者について: nipponese

Nipponese News編集部は、国内外のニュースを日本語で分かりやすくお届けします。